1Tomitaka S, Tomitaka M, Tolliver BK, et al. Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK-801) injures pyramidal neurons in rat retrosplenial cortex. Eur J Neurosci.2000,12(4): 1420-1430.
2Nelson SR, Howard RB, Cross RS,et al. Ketamine-induced changes in regional glucose utilization in the rat brain. Anesthesiology.1980,52 (4): 330-334.
3Sharp FR, Tomitaka M, Bemaudin M, et al. Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia? Trends Neurosci. 2001,24(6) :330-334.
4Colboume F, Rakic D, Auer RN. The effects of temperature and scopolamine on N-methyl-D-aspartate antagonist-induced neuronal necrosis in the rat. Neuroscience. 1999,90( 1 ): 87-94.
5White PF, Way WL, Trevor AJ. Ketamine-its pharmacology and therapeutic uses. Anesthesiology. 1982,56(2): 119-136.
6Bowdle TA, Radant AD, Cowley DS, et al. Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiology. 1998,88 ( 1 ): 82-88.
7Simon RP, Swan JH, Griffiths T, et al. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain.Science. 1984,226 ( 4676 ): 850-852.
8Olney JW, Labruyere J, Price MT. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science.1989,244(4910): 1360-1362.
9Sharp FR, Jasper P, Hall J, et al. MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex. Ann Neurol. 1991,30(6) :801-809.
10Nakao S, Arai T, Mori K, et al. High-dose ketamine does not induce c-Fos protein expression in rat hippocampus. Neurosci Lett. 1993,151(1) :33-36.
